Location History:
- Daejeon, KR (2017)
- Incheon, KR (2021)
Company Filing History:
Years Active: 2017-2021
Title: Eun A Kim - Innovator in Antibody Expression Technology
Introduction
Eun A Kim is a prominent inventor based in Incheon, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for antibody expression. With a total of 2 patents, her work has the potential to impact cancer treatment and diagnostics.
Latest Patents
Eun A Kim's latest patents include a bicistronic expression vector for antibody expression and a method for producing antibodies using the same. This invention relates to a bicistronic expression vector that includes a first expression cassette and a second expression cassette, allowing for the efficient expression of desired antibodies. The vector is designed to produce antibodies by culturing transfected animal cells with high stability and efficiency. Another notable patent is for a monoclonal antibody that specifically binds to delta-like ligand 4 (DLL4). This antibody is aimed at inhibiting the interaction between DLL4 and the Notch receptor, with applications in cancer prevention and treatment, as well as autoimmune disease management.
Career Highlights
Eun A Kim has worked with notable companies in the biotechnology sector, including Abl Bio Inc. and Prestige Biopharma Pte. Ltd. Her experience in these organizations has contributed to her expertise in antibody development and expression technologies.
Collaborations
Eun A Kim has collaborated with talented individuals in her field, including Dong Heon Lee and Yu Bin Choi. These partnerships have fostered innovation and advancement in her research endeavors.
Conclusion
Eun A Kim is a distinguished inventor whose work in antibody expression technology holds promise for significant advancements in medical science. Her contributions are paving the way for new therapeutic approaches in cancer treatment and diagnostics.